Stargem Consulting Group Ltd, acting as financial advisor for UNITY MED CAPITAL Ltd – Dr. Michalis Chrysostomou family investment company – facilitated a new strategic investment in VINCULA BIOTECH
GROUP.
VINCULA BIOTECH GROUP is leader in research and application in the fields of Regenerative Medicine, Stem-Cell and Gene therapies covering the entire chain. In addition, VINCULA BIOTECH GROUP owns and operates two private hospitals in Serbia and maintains in Slovenia a BIO INSTITUTE with the companies EDUCELL and BIOBANKA, which specialize in the development of biotechnology, the manufacture of cell therapies and the cryopreservation of blood, cells and tissues.
All applications are GMP certified and the research carried out at EDUCELL leads researchers to Doctoral Degrees.